title: Contribution of prostacyclin to D-tubocurarine-induced hypotension in humans.
abstract: In order to evaluate the role of prostacyclin in d-tubocurarine-induced hypotension in human, the authors examined the relationship of changes of arterial blood pressure and plasma 6-keto-PGF1 alpha level following iv administration of d-tubocurarine (dTc), with or without prior administration of aspirin and H1 antagonist. The bolus injection of dTc 0.6 mg/kg caused a significant decrease in mean arterial pressure (MAP) that was associated with a significant increase in plasma 6-keto-PGF1 alpha (P less than 0.05 in both). The maximum MAP decrease and plasma 6-keto-PGF1 alpha increase were noted at 2 min after dTc administration. Pretreatment with aspirin DL-lysine (25 mg/kg) or diphenhydramine (1 mg/kg) significantly attenuated the responses of MAP (P less than 0.05 in both) and plasma 6-keto-PGF1 alpha level (P less than 0.01 for aspirin group, P less than 0.05 for diphenhydramine group). There was a significant correlation between the changes in plasma 6-keto-PGF1 alpha and those in MAP (Kendall tau (tau) = -0.504, P less than 0.01). These findings suggest that a bolus injection of dTc induces a release of prostacyclin through H1 receptor, which is responsible for the dTc-induced transient decrease of blood pressure in humans.
authors.affiliation: Department of Anesthesia, Kyoto University Hospital, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Hatano
authors.forename: T
authors.initials: T
authors.lastname: Arai
authors.forename: J
authors.initials: J
authors.lastname: Noda
authors.forename: K
authors.initials: K
authors.lastname: Komatsu
authors.forename: R
authors.initials: R
authors.lastname: Shinkura
authors.forename: Y
authors.initials: Y
authors.lastname: Nakajima
authors.forename: M
authors.initials: M
authors.lastname: Sawada
authors.forename: K
authors.initials: K
authors.lastname: Mori
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000328:Adult; D001241:Aspirin / Q000031:analogs & derivatives / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004155:Diphenhydramine / Q000494:pharmacology; D011464:Epoprostenol / Q000502:physiology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D008239:Lysine / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D013268:Stimulation, Chemical; D014403:Tubocurarine / Q000494:pharmacology*
chemical_list: D015121:6-Ketoprostaglandin F1 alpha; D004155:Diphenhydramine; D011464:Epoprostenol; D008239:Lysine; D001241:Aspirin; D014403:Tubocurarine; C010395:acetylsalicylic acid lysinate